Multiple human papilloma virus infections predominant in squamous cell cervical carcinoma in Bandung

Main Article Content

Edhyana Sahiratmadja
Maringan D.L Tobing
Birgitta M Dewayani
Bethy S Hernowo
Herman Susanto


BACKGROUND Persistent infection of high risk genotypes of human papilloma virus (hrHPV) has been established as the etiological cause for cervical cancer, and the most prevalent genotypes that infect the cervical tissue are HPV-16 and HPV-18. However, HPV genotype profile has been shown to differ according to geographical distribution across the globe. The present study aimed to determine the HPV genotype distribution in cervical cancer patients from Bandung, Indonesia. METHODS During the period of July – November 2010 viral DNA was extracted from randomly chosen cervical cancer biopsies and subjected to genotype determination using the diagnostic linear array genotyping test (Roche). The distribution of HPV genotypes was explored and the prevalence of HPV genotypes was mapped. RESULTS Of 96 cervical cancer tissue samples, 76 (79.2%) were histopathologically classified as squamous cell cervical carcinoma. Due to the high cost of HPV genotyping tests, only twenty-five samples were randomly genotyped. Almost 90% of the cervical cancer patients were multiply infected with HPV-16 in combination with HPV-18, HPV-45, or HPV-52. The HPV-16 genotype had the highest prevalence, all samples being infected with HPV-16. CONCLUSION The cervical cancer cases were predominantly infected by multiple hrHPVs with HPV-16 as the major genotype among other hrHPVs, supporting the carcinogenic role of this hrHPV. Therefore, screening for hrHPVs in the general population is urgently needed as a means of early detection of cervical cancer.

Article Details

How to Cite
Sahiratmadja, E., Tobing, M. D., Dewayani, B. M., Hernowo, B. S., & Susanto, H. (2014). Multiple human papilloma virus infections predominant in squamous cell cervical carcinoma in Bandung. Universa Medicina, 33(1), 58–64.
Review Article


Castellsagué X. Natural history and

epidemiology of HPV infection and cervical

cancer. Gynecol Oncol 2008;110 Suppl 2:S4-7.

Aziz MF. Gynecological cancer in Indonesia.

Gynecol Oncol 2009;20:8-10.

Khenchouche A, Sadouki N, Boudriche A,

Houali K, Graba A, Ooka T, et al. Human

papillomavirus and Epstein-Barr virus coinfection

in cervical carcinoma in Algerian

women. Virol J 2013;10:340. doi:10.1186/1743-


Bruni L, Diaz M, Castellsague X, Ferrer E,

Bosch FX, de Sanjosé S. Cervical human

papillomavirus prevalence in 5 continents: metaanalysis

of 1 million women with normal

cytological findings. J Infect Dis 2010;202:1789-

de Sanjose S, Quint WG, Alemany L, Geraets

DT, Klaustermeier JE, Lloveras B for

Retrospective International Survey and HPV

Time Trends Study Group. Human

papillomavirus genotype attribution in invasive

cervical cancer: a retrospective cross-sectional

worldwide study. Lancet Oncol 2010;11:1048-

de Sanjosé S, Diaz M, Castellsagué X, Clifford

G, Bruni L, Munoz N. Worldwide prevalence and

genotype distribution of cervical human

papillomavirus DNA in women with normal

cytology: a meta-analysis. Lancet Infect Dis


Sjoeborg KD, Tropé A, Lie AK, Jonassen CM,

Steinbakk M, Hansen M. HPV genotype

distribution according to severity of cervical

neoplasia. Gynecol Oncol 2010;118:29-34.

Coutlée F, Ratnam S, Ramanakumar AV, Insinga

RR, Bentley J, Escott N, et al. Distribution of

human papillomavirus genotypes in cervical

intraepithelial neoplasia and invasive cervical

cancer in Canada. J Med Virol 2011;83:1034-

de Boer MA, Vet JN, Aziz MF, Cornain S,

Purwoto G, van den Akker BE, et al. Human

papillomavirus type 18 and other risk factors for

cervical cancer in Jakarta, Indonesia. Int J

Gynecol Cancer 2006;16:1809-14.

Vet JN, de Boer MA, van den Akker BE, Siregar

B, Lisnawati, Budiningsih S, et al. Prevalence

of human papillomavirus in Indonesia: a

population-based study in three regions. Br J

Cancer 2008;99:214-8.

Lax S. Histophatology of cervical precursor

lesions and cancer. Acta Dermatovenerol Alp

Panonica Adriat 2011;20:125-33.

Schiller JT, Day PM, Kines RC. Current

understanding of the mechanism of HPV

infection. Gynecol Oncol 2010;118 Suppl: S12-

Stanley M. HPV-immune response to infection

and vaccination. Infect Agent Cancer 2010;5:19.


Munoz N, Bosch FX, de Sanjose S, Herrero

R, Castellsague X, Shah KV, et al. Epidemiologic

classification of human papillomavirus types

associated with cervical cancer. N Engl J Med


Schellekens MC, Dijkman A, Aziz MF, Siregar

B, Cornain S, Kolkman-Uljee S, et al. Prevalence

of single and multiple HPV types in cervical

carcinomas in Jakarta, Indonesia. Gynecol Oncol


Wong FKY, Ching JCY, Chow JKF. Comparison

of the DiagCor GenoFlow human papillomavirus

array test and Roche linear array HPV

genotyping test. Open Virol J 2010;4:169–74.

Panigoro R, Susanto H, Novel SS, Hartini S,

Sahiratmadja E. HPV genotyping linear assay

test comparison in cervical cancer patients:

implications for HPV prevalence and molecular

epidemiology in a limited-resource area in

Bandung, Indonesia. Asian Pac J Cancer Prev


Dona MG, Benevolo M, Pimpinelli F, Battista

M, Rollo F, Stivali F. Comparative evaluation of

different DNA extraction methods for

HPV genotyping by linear array and INNOLiPA.

J Med Virol 2011;83:1042-7.

Domingo EJ, Noviani R, Noor MR, Ngelangel

CA, Limpaphayom KK, Thuan TV, et al.

Epidemiology and prevention of cervical cancer

in Indonesia, Malaysia, the Philippines, Thailand

and Vietnam. Vaccine 2008;26 Suppl 12:M71-